Denise M. Boudreau, PhD, MS, BS
Affiliate Associate Professor, Department of Pharmacy (primary department)
Affiliate Associate Professor, Epidemiology
Dr. Boudreau is involved in a wide array of pharmacoepidemiology and pharmacoeconomic research projects at Group Health and across the HMO Research Network (HMORN). She has extensive experience working with automated health plan data and bring expertise in the areas of observational study design/comparative effectiveness, managed care, drug safety, and economic evaluation. She has been the HMORN Steering Committee Representative on the FDA Mini Sentinel Initiative since 2009. Her main research interests include cancer pharmacoepidemiology, opioid safety, bone health, and cost of cancer.
Group Health Research Institute
1730 Minor Ave, Suite 1600
Seattle, WA 98101
Pharmacoepidemiology and pharmacoeconomics
Pharmacoepidemiology, Epi/Pharm 533
PhD, Pharmacoepidemiology, University of Washington, School of Pharmacy 2002
MS, Pharmacy Administration, University of Rhode Island, School of Pharmacy 1996
BS, Pharmacy, University of Rhode Island 1992
Commonly used medications and breast cancer outcomes; Metformin use and risk of various site specific cancers; Scalable Partnering Network for Comparative Effectiveness Research: Across Lifespan, Conditions, and Settings; Efforts to develop the FDA Mini-Sentinel Initiative; Predictors of bone healing complications as a drug safety endpoint.
Last Reviewed on 2/27/2013